Lipid Metabolism Disorders clinical trials

Explore recruiting lipid metabolism disorders clinical trials.

Recruiting lipid metabolism disorders studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Lipid Metabolism Disorders trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase IIb, Multicenter, Randomized, Parallel-group, Double- blind, Placebo-controlled, Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AZD0780 in Participants with Dyslipidemia

Denmark, Czechia, Spain, Slovakia, Hungary

Therapeutic exploratory (Phase II) EU CTIS Study details

Lipid Metabolism Disorders trials by city

Lipid Metabolism Disorders clinical trials

Recruiting lipid metabolism disorders studies right now

Prospective Exploratory Study on the Comprehensive Application Effectiveness of Exercise Prescription Decision Support Tools in the Management of Patients With "Four Highs" (Hypertension, Hyperglycemia, Hyperlipidemia, Hyperuricemia)

Akkermansia Muciniphilia and Metabolic Side Effects of ADT

Reversal of Lipid-Induced Insulin Resistance

Penn Medicine Healthy Heart

Nutrition Intervention for Pancreatic Cancer

A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis

A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia

IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia

64Cu-GRIP B in Patients With Advanced Malignancies

A Study to Evaluate the Safety and Efficacy of Nizubaglustat (AZ-3102) in Patients With GM2 Gangliosidosis or Niemann-Pick Type C Disease

A First-in-Human, Single- and Multiple-Ascending Dose Study of YH35995 in Healthy Adult Male Participants

A Study of SRSD216 in Patients With Elevated Lipoprotein (a)

Also recruiting in Europe

A Phase IIb, Multicenter, Randomized, Parallel-group, Double- blind, Placebo-controlled, Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AZD0780 in Participants with Dyslipidemia

Lipid Metabolism Disorders trials by city

Other conditions